SCHEMBL10778997

SCHEMBL10778997

CCCN(CCC)CCc1ccc(O)c(NS(C)(=O)=O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 3/20 0.64
ADRA2A P08913 2/20 0.64
ADRA2B P18089 2/20 0.64
ADRA2C P18825 2/20 0.64
DRD2 P14416 3/20 0.60
DRD3 P35462 3/20 0.60
DRD1 P21728 2/20 0.60
DRD4 P21917 2/20 0.60
DRD5 P21918 2/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
TSHR P16473 1/20 0.60
NFKB1 P19838 1/20 0.60
ADRA1D P25100 1/20 0.60
ADRA1B P35368 1/20 0.60
HIF1A Q16665 1/20 0.60
HSD17B10 Q99714 1/20 0.60
KDM4E B2RXH2 1/20 0.58
PMP22 Q01453 1/20 0.58
ADRB3 P13945 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13293368 0.80 ADRA2A (0.75) ADRA1AADRA2AADRA2BADRA2CTSHR
SCHEMBL10409066 0.80 DRD2 (0.61) ADRA1ADRD2DRD3DRD1DRD4
SCHEMBL9687730 0.79 ADRA2A (0.73) ADRA1AADRA2AADRA2BADRA2CDRD2
SCHEMBL10410236 0.78 DRD2 (0.60) ADRA1ADRD2DRD3DRD1DRD4
SCHEMBL10920785 0.77 DRD2 (0.58) ADRA1ADRD2DRD3DRD1DRD4
Bromide SCHEMBL10556621 0.77 KDM4E (0.61) ADRA1ADRD2DRD3DRD1DRD4
Bromide SCHEMBL10553193 0.76 KDM4E (0.59) ADRA1AADRA2AADRA2BADRA2CDRD2
SCHEMBL8632112 0.76 ADRA2A (0.69) ADRA1AADRA2AADRA2BADRA2CADRB3
SCHEMBL467093 0.76 DRD2 (1.00) ADRA1ADRD2DRD3DRD1DRD4
SCHEMBL29368857 0.76 DRD2 (1.00) ADRA1ADRD2DRD3DRD1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0147114-B1 N,N-DI-N-PROPYL-4-HYDROXY-3-METHANESULFONAMIDOPHENETHYLAMINE SMITHKLINE BECKMAN CORPORATION (US) 1987-04-22 EP claimed
EP-0147114-A1 N,N-Di-N-propyl-4-hydroxy-3-methanesulfonamidophenethylamine SMITHKLINE BECKMAN CORPORATION (US) 1985-07-03 EP claimed
US-4507320-A Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine SMITHKLINE BECKMAN CORPORATION (US) 1985-03-26 US claimed
EP-0147114-B1 N,N-DI-N-PROPYL-4-HYDROXY-3-METHANESULFONAMIDOPHENETHYLAMINE SMITHKLINE BECKMAN CORPORATION (US) 1987-04-22 EP disclosed
EP-0147114-B1 N,N-DI-N-PROPYL-4-HYDROXY-3-METHANESULFONAMIDOPHENETHYLAMINE SMITHKLINE BECKMAN CORPORATION (US) 1987-04-22 EP disclosed
EP-0147114-A1 N,N-Di-N-propyl-4-hydroxy-3-methanesulfonamidophenethylamine SMITHKLINE BECKMAN CORPORATION (US) 1985-07-03 EP disclosed
EP-0147114-A1 N,N-Di-N-propyl-4-hydroxy-3-methanesulfonamidophenethylamine SMITHKLINE BECKMAN CORPORATION (US) 1985-07-03 EP disclosed
EP-0147114-A1 N,N-Di-N-propyl-4-hydroxy-3-methanesulfonamidophenethylamine SMITHKLINE BECKMAN CORPORATION (US) 1985-07-03 EP disclosed
US-4507320-A Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine SMITHKLINE BECKMAN CORPORATION (US) 1985-03-26 US disclosed
US-4507320-A Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine SMITHKLINE BECKMAN CORPORATION (US) 1985-03-26 US disclosed
US-4507320-A Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine SMITHKLINE BECKMAN CORPORATION (US) 1985-03-26 US disclosed